Step 1: Enter Vial Strength Input the total amount of BPC-157 in the vial, such as 5 mg or 10 mg
Key red flags include pregnancy (no safety data, so contraindicated), active cancer (caution due to growth effects), autoimmune disorders, or organ failure
Schedule your consultation to learn whether glutathione injections align with your needs
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
CJC-1295/Ipamorelin is a growth hormone secretagogue combination that stimulates pulsatile GH release mimicking the bodys natural overnight pattern
BPC-157 has shown interactions with vagal signaling in animal models, though the specifics of this interaction are still being characterized